(Q38427788)

English

Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study

scientific article published on 08 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study (English)

1 reference

Europe PubMed Central

3 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Saverio Ligato

1

1 reference

Europe PubMed Central

3 September 2017

Daniza Mandich

2

1 reference

Europe PubMed Central

3 September 2017

Richard W Cartun

3

1 reference

Europe PubMed Central

3 September 2017

publication date

8 February 2008

1 reference

Europe PubMed Central

3 September 2017

Modern Pathology

1 reference

Europe PubMed Central

3 September 2017

21

1 reference

Europe PubMed Central

3 September 2017

5

1 reference

Europe PubMed Central

3 September 2017

626-631

1 reference

Europe PubMed Central

3 September 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.26

0 references

Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

21 January 2018

Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

21 January 2018

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

21 January 2018

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

21 January 2018

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

21 January 2018

Glypican-3 as a serum marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

7 January 2021

based on heuristic

inferred from DOI database lookup

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

7 January 2021

based on heuristic

inferred from DOI database lookup

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

7 January 2021

based on heuristic

inferred from DOI database lookup

Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

7 January 2021

based on heuristic

inferred from DOI database lookup

Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.26

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2008.26

1 reference

Europe PubMed Central

3 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38427788&oldid=1758827635"